UIM
TECH icon

USS Investment Management’s Bio-Techne TECH Stock Holding History

USS Investment Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11,628
Closed -$1.01M – 690
2022
Q2 		$1.01M Sell
11,628
-2,224
-16% -$208K 0.01% 605
2022
Q1 		$1.5M Sell
13,852
-20,424
-60% -$2.11M 0.01% 603
2021
Q4 		$4.44M Hold
34,276
– – 0.03% 471
2021
Q3 		$4.15M Buy
+34,276
New +$4.17M 0.04% 475

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

USS Investment Management's TECH Position: Q3 2022 in Review

USS Investment Management sold out of Bio-Techne (TECH) in Q3 2022, closing a stake of 11,628 shares — an estimated $1.01M sold.

USS Investment Management first reported a position in TECH in Q3 2021 and held it in 4 quarters. The position peaked at $4.44M in Q4 2021. 536 funds tracked by Wall St. Rank hold TECH as of Q3 2022.

  • USS Investment Management reported no remaining Bio-Techne position as of Q3 2022 after selling out during the quarter.
  • USS Investment Management sold 11,628 Bio-Techne shares in Q3 2022, an estimated $1.01M.
  • USS Investment Management first reported a position in Bio-Techne in Q3 2021 and held it in 4 quarters.
  • USS Investment Management's Bio-Techne position peaked at $4.44M in Q4 2021.
  • 536 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2022.

Based on USS Investment Management's 13F filing for Q3 2022, filed 8 Nov 2022.